GlaxoSmithKline is trading at $50.80, up 5.56% after the regular session closed at $48.12 on September 11, 2026, amid broad market strength.
- The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average all advanced more than 0.5%.
- No new company-specific announcement clearly explains the after-hours surge.
- Recent news included a German vaccine-plant closure and Japanese Shingrix approval, but neither directly accounts for the move.